Here are a number of compelling reasons to consider seeking out a mentor to help you with your neurology career.
A dementia expert addresses current controversies on proton pump inhibitors.
Here is new evidence that people aged 75 and older who take aspirin-based antiplatelet treatment for secondary prevention should also take PPIs.
This case serves as a reminder to consider Baclofen overdose in the differential of select patients who present with unresponsiveness and respiratory distress.
Here is a quick primer on currently available MS therapies for partners in a patient’s healthcare team and also for patients.
Here is evidence that metformin, especially at high doses and for long periods, is associated with increased risk for neurodegenerative diseases and dementia.
New findings may have an impact on reducing the epilepsy disease burden in future generations.
New studies shed light on the potential role of monoclonal antibodies in migraine prophylaxis and in Parkinson disease and on a common genetic pathway shared by PD and autoimmune diseases.
Medication Discontinuation in Patients With Multiple Sclerosis: A Conversation With John R. Corboy, MD
The pros and cons of discontinuing disease-modifying therapies in multiple sclerosis.
Here's a pop quiz on headaches to test your clinical acumen.
Test your headache IQ here.
Can you answer these 3 questions on headaches?
How best ensure an accurate ADHD diagnosis in the absence of an established gold-standard or neuroimaging test or biomarker?
The anticonvulsant known as Potiga (ezogabine) in the US and as Trobalt (retigabine) in Europe will be discontinued by the manufacturer at the end of June. Details here.
Here’s evidence that ALF may be an important memory disorder in subgroups of patients with epilepsy.